概括
面骨肌缩症 (FSHD) 是由有毒的DUX4基因表达引起的,导致肌肉逐渐疲软. 针对DUX4的新疗法正在推进,为改变疾病的治疗提供了希望.
科学领域:
- 遗传学和分子生物学
- 神经学 神经学
- 临床治疗学 临床治疗学
背景情况:
- 面骨肌肉发育不良 (FSHD) 是一种常见的,进展性神经肌肉疾病,严重程度可变.
- 它的特征是影响脸部,肩膀和四肢的肌肉衰弱,并且可以包括肌肉外症状.
- 儿科发病的FSHD可能会出现更严重的特征,包括听力损失和认知问题.
研究的目的:
- 提供FSHD的全面概述,涵盖其遗传基础,临床表现和当前/新兴治疗方法.
- 要突出DUX4基因错误表达在FSHD病变发生中的作用.
- 讨论疾病修饰疗法临床试验的不断变化的格局.
主要方法:
- 对FSHD背后的遗传机制的审查.
- 对临床表现的分析,包括儿科特异性特征.
- 检查当前和未来的治疗策略和临床试验.
主要成果:
- FSHD是由有毒的DUX4转录因子脱抑引起的,影响骨肌肉.
- 渐进的肌肉衰弱,往往不对称,肌肉外症状是关键特征.
- 了解DUX4的进展刺激了向治疗和临床试验的发展.
结论:
- FSHD是由有毒的DUX4表达驱动的,导致特征性的肌肉虚弱和潜在的肌肉外问题.
- 该领域正在朝着针对FSHD的向性,疾病修饰性治疗方向发展.
- 临床试验正在进行中,标志着FSHD患者治疗开发的新时代.
相关概念视频
Satellite Stem Cells and Muscular Dystrophy
2.3K
Satellite stem cells or myosatellite cells are quiescent stem cells that Alexander Mauro first identified in 1961. These cells are located between the sarcolemma, the plasma membrane of muscle fibers, and the basal lamina, the connective tissue sheath covering it. These mononucleated cells are activated in response to muscle injury, can transform into myoblasts, and may form or repair muscle fibers. Myosatellite cells can provide additional myonuclei for muscle regeneration or return to a...
2.3K
Cardiomyopathy III: Hypertrophic Cardiomyopathy
354
Hypertrophic cardiomyopathy, or HCM, is an autosomal dominant genetic disorder characterized by asymmetric left ventricular hypertrophy without ventricular dilation. It is more common in men and is typically diagnosed in young, athletic adults.EtiologyHCM is primarily genetic and is caused by mutations in genes encoding sarcomeric proteins. Researchers have identified over 1400 mutations across at least 11 different genes. Among these, the most frequently occurring mutations are found in the...
354
Cross-bridge Cycle
121.9K
As muscle contracts, the overlap between the thin and thick filaments increases, decreasing the length of the sarcomere—the contractile unit of the muscle—using energy in the form of ATP. At the molecular level, this is a cyclic, multistep process that involves binding and hydrolysis of ATP, and movement of actin by myosin.
121.9K
Disorders of the Skeletal Muscle
1.6K
The clinical conditions affecting the skeletal muscle tissue are broadly categorized as musculoskeletal and neuromuscular disorders.
Musculoskeletal disorders
Musculoskeletal disorders involve injuries and conditions affecting the skeletal muscles and associated connective tissues. These disorders can arise from acute biomechanical stresses or chronic overuse and can occur across different age groups. Common injuries include sprains, fractures, and muscular strains, often resulting from...
Musculoskeletal disorders
Musculoskeletal disorders involve injuries and conditions affecting the skeletal muscles and associated connective tissues. These disorders can arise from acute biomechanical stresses or chronic overuse and can occur across different age groups. Common injuries include sprains, fractures, and muscular strains, often resulting from...
1.6K
Muscles that Move the Arm
4.5K
Nine muscles are involved in arm movements. Two of these, the pectoralis major and latissimus dorsi, originate from the axial skeleton and are called axial muscles. The other seven originate from the scapula and are called the scapular muscles.
The pectoralis major has two origins. Its clavicular head originates on the medial half of the clavicle. In contrast, the sternocostal head originates on the costal cartilages of ribs 1-6, the sternum, and the aponeurosis of the external oblique of the...
The pectoralis major has two origins. Its clavicular head originates on the medial half of the clavicle. In contrast, the sternocostal head originates on the costal cartilages of ribs 1-6, the sternum, and the aponeurosis of the external oblique of the...
4.5K
Myasthenia Gravis: Overview and Treatment
2.7K
Myasthenia gravis is a neuromuscular transmission disorder characterized by weakness and increased fatigability of skeletal muscles. It is an autoimmune disease affecting approximately one in 2000 people, where antibodies against the α1 subunit of nicotinic acetylcholine receptors are produced.
These antibodies interfere with the function of the nicotinic receptors in three ways: by binding to the receptor and disrupting acetylcholine binding; by causing cross-linking of receptors which...
These antibodies interfere with the function of the nicotinic receptors in three ways: by binding to the receptor and disrupting acetylcholine binding; by causing cross-linking of receptors which...
2.7K


